N-METHYL-(R)-2-[(R)-2-(HYDROXYAMINO)-1-(2-HYDROXYACETYLAMINO)-2-OXO-ETHYL]-5-PHENYLPENTANOYL-(S)-PHENYLALANINEAMIDE
Compound with spectra: 1 NMR
![N-METHYL-(R)-2-[(R)-2-(HYDROXYAMINO)-1-(2-HYDROXYACETYLAMINO)-2-OXO-ETHYL]-5-PHENYLPENTANOYL-(S)-PHENYLALANINEAMIDE](/api/compound/4Tw1wmHsdnx.png?ph=true&h=300&w=458 "N-METHYL-(R)-2-[(R)-2-(HYDROXYAMINO)-1-(2-HYDROXYACETYLAMINO)-2-OXO-ETHYL]-5-PHENYLPENTANOYL-(S)-PHENYLALANINEAMIDE")
| SpectraBase Compound ID | 4Tw1wmHsdnx |
|---|---|
| InChI | InChI=1S/C25H32N4O6/c1-26-24(33)20(15-18-11-6-3-7-12-18)27-23(32)19(14-8-13-17-9-4-2-5-10-17)22(25(34)29-35)28-21(31)16-30/h2-7,9-12,19-20,22,30,35H,8,13-16H2,1H3,(H,26,33)(H,27,32)(H,28,31)(H,29,34)/t19-,20+,22-/m1/s1 |
| InChIKey | IMEMVACYQIBWGZ-RZUBCFFCSA-N |
| Mol Weight | 484.6 g/mol |
| Molecular Formula | C25H32N4O6 |
| Exact Mass | 484.232185 g/mol |
| Enantiomer InChIKey | IMEMVACYQIBWGZ-VWPQPMDRSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
(2R,3R)-2-(TERT.-BUTOXYCARBONYLAMINO)-3-[(S)-1-(METHYLAMINO)-1-OXO-3-PHENYLPROPAN-2-YL-CARBAMOYL]-6-PHENYL-HEXANOIC-ACID
STELLARIN-B;CYClO-(GLY-SER-HOILE-PHE-PHE-ALA)
STELLARIN-C;CYClO-(GLY-SER-HOILE-PHE-PHE-SER)
YUNNANIN-E
DICHOTOMIN_J;CYCLO-(-GLY-ILE-PHE-LEU-TYR-ALA-)
BENZYL-[(2R)-N-BENZYLOXYCARBONYL-ALPHA-METHYLASPARTYL]-BETA-(2S)-PHENYLALANYL-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-GLYCINATE-TRIESTER
SOLONAMIDE-A
FMOC_CLEAVAGE_CONDITIONS
SIGNALSET-#1;N-[N'-(METHOXYCARBONYLCARBONYL)-L-PROPYL]-L-PHENYLALANINE-BENZYLESTER
BETA-BENZYL-(2S)-N-(TERT.-BUTOXYCARBONYL)-PHENYLALANYL-BETA-ALANYL-[ALPHA-METHYL-(2R)-GLUTAMYL]-GAMMA-SARCOSYL-[ALPHA-METHYL-(2R)-ASPARTATE]-TRIESTER
| Title | Journal or Book | Year |
|---|---|---|
| A Straightforward Approach to MMP-2 and MMP-9 Inhibitors Based on Chelate Claisen Rearrangements | European Journal of Organic Chemistry | 2011 |